Identification and evaluation of biomarkers for diagnosis of chronic hepatitis B using RNA-seq

Background & aim: Chronic hepatitis B (CHB) is a global public health problem affecting hundreds of millions of people and is associated with significant morbidity and mortality of liver cancer. Exosomes originate from cells and their detection in biofluids provides valuable insights into ce...

Full description

Saved in:
Bibliographic Details
Main Authors: Hong Hong, Xintong Han, Qiuxiang Hu, Huafeng Song, Bing Han
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Virus Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0168170225000668
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849421745644109824
author Hong Hong
Xintong Han
Qiuxiang Hu
Huafeng Song
Bing Han
author_facet Hong Hong
Xintong Han
Qiuxiang Hu
Huafeng Song
Bing Han
author_sort Hong Hong
collection DOAJ
description Background & aim: Chronic hepatitis B (CHB) is a global public health problem affecting hundreds of millions of people and is associated with significant morbidity and mortality of liver cancer. Exosomes originate from cells and their detection in biofluids provides valuable insights into cellular and tissue alterations, thus reflecting underlying pathological states. The aim of this study was to provide exosomal RNA biomarkers of CHB and develop a machine learning model for the non-invasive diagnosis of CHB patients. Methods: The differentially expressed genes (DEGs) were screened according to the RNA-seq data of normal and CHB liver tissues. The biomarkers were selected according to the analysis of pathway enrichment and functional annotation. The correlation of biomarkers’ expression level with the inflammation stage of CHB patients was analyzed. The non-invasive diagnostic value of the potential RNA biomarkers was evaluated by checking their different expression level in the plasma exosome of healthy individuals and CHB patients. A machine learning model was constructed to diagnose CHB by combining three identified biomarkers. Results: A total of 1,006 differential expressed genes (569 upregulated and 437 downregulated) were screened between normal and CHB tissues. The GO and KEGG results showed the DEGs were mainly enriched in inflammation-related pathways. Among these genes, the expression of 4 upregulated genes and 27 downregulated genes showed consistent trends with the inflammation stage utilizing an independent CHB dataset. Three (PXN-AS1, RAD9A, SLC17A9) of 27 downregulated genes were found significantly decreased in plasma exosome of CHB patients. ROC analysis revealed that PXN-AS1, RAD9A and SLC17A9 exhibited moderate diagnostic performance in distinguishing CHB from healthy controls, with AUC values of 0.743, 0.762, and 0.665 respectively. A machine learning model, Adaboost classifier, was constructed to detect CHB by combining exosomal expression of PXN-AS1, RAD9A and SLC17A9. The AUC of the model was 0.983 and 0.924 for CHB detection in train and test dataset respectively. Conclusion: Based on multiple RNA-seq data of tissues and plasma exosomes, we identified PXN-AS1, RAD9A, SLC17A9 as diagnostic biomarkers for CHB detection. The model based on three biomarkers showed potential diagnostic value for detecting CHB. Additional validation with a larger sample size is essential to thoroughly assess the reliability of these three biomarkers and the model's performance.
format Article
id doaj-art-5c37c08da4ac4d62af4bca4933f0664e
institution Kabale University
issn 1872-7492
language English
publishDate 2025-08-01
publisher Elsevier
record_format Article
series Virus Research
spelling doaj-art-5c37c08da4ac4d62af4bca4933f0664e2025-08-20T03:31:23ZengElsevierVirus Research1872-74922025-08-0135819958910.1016/j.virusres.2025.199589Identification and evaluation of biomarkers for diagnosis of chronic hepatitis B using RNA-seqHong Hong0Xintong Han1Qiuxiang Hu2Huafeng Song3Bing Han4Department of Clinical Laboratory, Nantong Hospital of Traditional Chinese Medicine, Nantong, Jiangsu, PR ChinaSchool of Chemical Biology and Pharmaceutical Sciences, Capital Medical University, Beijing, PR ChinaBamRock Research Department, Suzhou BamRock Biotechnology Ltd., Suzhou, Jiangsu Province, PR ChinaDepartment of Clinical Laboratory, The Fifth People’s Hospital of Suzhou, Infectious Disease Hospital Affiliated to Soochow University, Suzhou, Jiangsu Province, PR China; Corresponding authors.Department of Hepatobiliary and Transplantation Surgery, Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital, Nanjing, Jiangsu Province, PR China; Corresponding authors.Background & aim: Chronic hepatitis B (CHB) is a global public health problem affecting hundreds of millions of people and is associated with significant morbidity and mortality of liver cancer. Exosomes originate from cells and their detection in biofluids provides valuable insights into cellular and tissue alterations, thus reflecting underlying pathological states. The aim of this study was to provide exosomal RNA biomarkers of CHB and develop a machine learning model for the non-invasive diagnosis of CHB patients. Methods: The differentially expressed genes (DEGs) were screened according to the RNA-seq data of normal and CHB liver tissues. The biomarkers were selected according to the analysis of pathway enrichment and functional annotation. The correlation of biomarkers’ expression level with the inflammation stage of CHB patients was analyzed. The non-invasive diagnostic value of the potential RNA biomarkers was evaluated by checking their different expression level in the plasma exosome of healthy individuals and CHB patients. A machine learning model was constructed to diagnose CHB by combining three identified biomarkers. Results: A total of 1,006 differential expressed genes (569 upregulated and 437 downregulated) were screened between normal and CHB tissues. The GO and KEGG results showed the DEGs were mainly enriched in inflammation-related pathways. Among these genes, the expression of 4 upregulated genes and 27 downregulated genes showed consistent trends with the inflammation stage utilizing an independent CHB dataset. Three (PXN-AS1, RAD9A, SLC17A9) of 27 downregulated genes were found significantly decreased in plasma exosome of CHB patients. ROC analysis revealed that PXN-AS1, RAD9A and SLC17A9 exhibited moderate diagnostic performance in distinguishing CHB from healthy controls, with AUC values of 0.743, 0.762, and 0.665 respectively. A machine learning model, Adaboost classifier, was constructed to detect CHB by combining exosomal expression of PXN-AS1, RAD9A and SLC17A9. The AUC of the model was 0.983 and 0.924 for CHB detection in train and test dataset respectively. Conclusion: Based on multiple RNA-seq data of tissues and plasma exosomes, we identified PXN-AS1, RAD9A, SLC17A9 as diagnostic biomarkers for CHB detection. The model based on three biomarkers showed potential diagnostic value for detecting CHB. Additional validation with a larger sample size is essential to thoroughly assess the reliability of these three biomarkers and the model's performance.http://www.sciencedirect.com/science/article/pii/S0168170225000668Chronic hepatitis BExosome RNA-seqSerum biomarkersBioinformatics analysisNon-invasive diagnosis
spellingShingle Hong Hong
Xintong Han
Qiuxiang Hu
Huafeng Song
Bing Han
Identification and evaluation of biomarkers for diagnosis of chronic hepatitis B using RNA-seq
Virus Research
Chronic hepatitis B
Exosome RNA-seq
Serum biomarkers
Bioinformatics analysis
Non-invasive diagnosis
title Identification and evaluation of biomarkers for diagnosis of chronic hepatitis B using RNA-seq
title_full Identification and evaluation of biomarkers for diagnosis of chronic hepatitis B using RNA-seq
title_fullStr Identification and evaluation of biomarkers for diagnosis of chronic hepatitis B using RNA-seq
title_full_unstemmed Identification and evaluation of biomarkers for diagnosis of chronic hepatitis B using RNA-seq
title_short Identification and evaluation of biomarkers for diagnosis of chronic hepatitis B using RNA-seq
title_sort identification and evaluation of biomarkers for diagnosis of chronic hepatitis b using rna seq
topic Chronic hepatitis B
Exosome RNA-seq
Serum biomarkers
Bioinformatics analysis
Non-invasive diagnosis
url http://www.sciencedirect.com/science/article/pii/S0168170225000668
work_keys_str_mv AT honghong identificationandevaluationofbiomarkersfordiagnosisofchronichepatitisbusingrnaseq
AT xintonghan identificationandevaluationofbiomarkersfordiagnosisofchronichepatitisbusingrnaseq
AT qiuxianghu identificationandevaluationofbiomarkersfordiagnosisofchronichepatitisbusingrnaseq
AT huafengsong identificationandevaluationofbiomarkersfordiagnosisofchronichepatitisbusingrnaseq
AT binghan identificationandevaluationofbiomarkersfordiagnosisofchronichepatitisbusingrnaseq